Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps
Authors' conclusion
This study reveals critical disparities in diabetes technology use across race, ethnicity and insurance type, particularly among people with type 1 diabetes. Evidentiary gaps assessing disparities in diabetes technology use persist, particularly concerning people with type 2 diabetes, Native American/American Indian and LGBTQ+ populations, and in outcomes related to continuation of use. Social and digital determinants of health, such as income, transportation, residential location and technological literacy, are crucial to achieving equitable access. Future research should focus on the patient journey to identify opportunities for equitable access to diabetes technology as its use grows.
Study context
- Population
- Real-world studies of disparities in CGM/insulin pump use in the United States36 studies
- Outcome
- Disparities in CGM/insulin pump utilization
Methodological detailsreal-world evidence
- Real-world evidence
Pooled result
As reported in the abstract
Studies included
36
Studies predominantly in people with T1D; studies including T2D
2
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →